BIB

Ultra Nasdaq Biotechnology

Investment Objective

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

Documents & Downloads

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB Market Price -12.17% -4.65% -23.66% -4.65% -14.82% -7.50% 1.19% -4.67% 13.38% 04/07/2010
BIB NAV -12.25% -4.72% -23.81% -4.72% -14.95% -7.45% 1.07% -4.69% 13.36% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    1.14%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 4/14/2025
  • NAV
    $42.62
  • NAV Change
    $+2.38 up caret
  • Market Price
    $42.55
  • Market Price Change
    $+2.31 up caret
  • Trading Volume (M)
    12,164
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Expense Ratio
    0.95%
  • Gross Expense Ratio
    1.14%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 4/14/2025
  • NAV
    $42.62
  • NAV Change
    $+2.38 up caret
  • Market Price
    $42.55
  • Market Price Change
    $+2.31 up caret
  • Trading Volume (M)
    12,164
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2025. Without the fee waiver performance would likely be lower.

Exposures

Index as of 3/31/2025

Holdings

as of 4/14/2025

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
7.08% VRTX VERTEX PHARMACEUTICALS INC -- $3,348,339.99 6,753 2931034
6.53% AMGN AMGEN INC -- $3,091,450.56 10,518 2023607
6.38% GILD GILEAD SCIENCES INC -- $3,018,742.50 28,345 2369174
5.24% REGN REGENERON PHARMACEUTICALS -- $2,480,684.64 4,344 2730190
3.38% AZN ASTRAZENECA PLC-SPONS ADR -- $1,600,139.28 23,528 2989044
2.65% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,255,492.31 5,231 B00FWN1
1.66% ARGX ARGENX SE - ADR -- $784,062.27 1,293 BDVLM39
1.65% SMMT SUMMIT THERAPEUTICS INC -- $778,830.78 29,806 BMTVQS7
1.49% BIIB BIOGEN INC -- $705,303.64 5,914 2455965
1.27% SNY SANOFI-ADR -- $601,862.40 11,610 2964557
1.20% RPRX ROYALTY PHARMA PLC- CL A -- $565,365.61 17,509 BMVP7Y0
1.10% INSM INSMED INC -- $519,442.39 7,313 2614487
1.09% UTHR UNITED THERAPEUTICS CORP -- $516,022.65 1,815 2430412
1.02% ILMN ILLUMINA INC -- $480,384.00 6,400 2613990
0.98% INCY INCYTE CORP -- $463,041.18 7,819 2471950
0.97% BMRN BIOMARIN PHARMACEUTICAL INC -- $459,936.36 7,708 2437071
0.88% MRNA MODERNA INC -- $417,785.20 15,589 BGSXTS3
0.87% BNTX BIONTECH SE-ADR -- $411,406.80 4,020 BK6H543
0.87% ONC BEIGENE LTD-ADR -- $410,490.25 1,691 BYYWPW6
0.85% EXEL EXELIXIS INC -- $404,183.66 11,309 2576941
0.81% NBIX NEUROCRINE BIOSCIENCES INC -- $382,311.81 4,029 2623911
0.80% ASND ASCENDIS PHARMA A/S - ADR -- $379,420.00 2,440 BV9G6B8
0.79% MEDP MEDPACE HOLDINGS INC -- $375,799.68 1,231 BDCBC61
0.78% VTRS VIATRIS INC -- $368,002.53 48,231 BMWS3X9
0.65% HALO HALOZYME THERAPEUTICS INC -- $305,476.64 4,976 2975098
0.62% ROIV ROIVANT SCIENCES LTD -- $293,787.89 28,831 BMW4NZ9
0.62% TEM TEMPUS AI INC -- $291,343.15 6,755 BSLSJJ0
0.61% MDGL MADRIGAL PHARMACEUTICALS INC -- $287,509.44 892 BD59BS7
0.58% RVMD REVOLUTION MEDICINES INC -- $273,962.64 7,512 BL71K91
0.57% BBIO BRIDGEBIO PHARMA INC -- $267,822.25 7,685 BK1KWG8
0.53% JAZZ JAZZ PHARMACEUTICALS PLC -- $249,694.50 2,454 B4Q5ZN4
0.48% GH GUARDANT HEALTH INC -- $225,212.92 4,987 BFXC911
0.45% SRPT SAREPTA THERAPEUTICS INC -- $214,204.23 3,921 B8DPDT7
0.45% BPMC BLUEPRINT MEDICINES CORP -- $213,092.46 2,582 BWY52P3
0.43% AXSM AXSOME THERAPEUTICS INC -- $203,954.10 1,970 BYZR4X4
0.42% ADMA ADMA BIOLOGICS INC -- $199,711.41 9,551 B9NSBM2
0.42% KRYS KRYSTAL BIOTECH INC -- $196,611.24 1,164 BD6JX35
0.40% CYTK CYTOKINETICS INC -- $190,451.04 4,784 BBBSBJ5
0.40% NUVL NUVALENT INC-A -- $187,110.00 2,673 BMVBZD3
0.39% IONS IONIS PHARMACEUTICALS INC -- $184,211.64 6,423 BDJ0LS6
0.39% VRNA VERONA PHARMA PLC - ADR -- $184,067.04 3,184 BYWPZK5
0.38% ALKS ALKERMES PLC -- $180,937.80 6,570 B3P6D26
0.35% PCVX VAXCYTE INC -- $166,704.12 5,203 BKPVGH6
0.32% RYTM RHYTHM PHARMACEUTICALS INC -- $153,657.70 2,555 BF2YWG4
0.30% PTCT PTC THERAPEUTICS INC -- $143,669.96 3,187 B17VCN9
0.28% CRSP CRISPR THERAPEUTICS AG -- $134,515.46 3,466 BDHF4K6
0.28% ACLX ARCELLX INC -- $133,866.00 2,220 BPCJ1Q2
0.28% RNA AVIDITY BIOSCIENCES INC -- $130,701.87 4,857 BMWHPY1
0.28% RARE ULTRAGENYX PHARMACEUTICAL IN -- $130,530.96 3,738 BJ62Z18
0.26% AKRO AKERO THERAPEUTICS INC -- $120,959.20 3,217 BK7Y2V9
0.25% MRUS MERUS NV -- $118,464.56 2,792 BZBY005
0.24% SWTX SPRINGWORKS THERAPEUTICS INC -- $113,428.88 3,028 BGMGM89
0.24% CRNX CRINETICS PHARMACEUTICALS IN -- $111,972.80 3,760 BDD19F8
0.24% PTGX PROTAGONIST THERAPEUTICS INC -- $111,674.40 2,480 BDCBCD8
0.23% SRRK SCHOLAR ROCK HOLDING CORP -- $110,657.25 3,825 BFZQ0L8
0.22% LEGN LEGEND BIOTECH CORP-ADR -- $105,995.11 3,301 BMX9K07
0.22% IMVT IMMUNOVANT INC -- $105,896.09 6,863 BJRFSB7
0.22% ALVO ALVOTECH SA -- $103,903.93 12,181 BPNTJ34
0.22% XENE XENON PHARMACEUTICALS INC -- $103,429.92 3,093 BRJ3GY4
0.21% VCYT VERACYTE INC -- $101,208.86 3,149 BFTWZY0
0.21% ACAD ACADIA PHARMACEUTICALS INC -- $100,141.54 6,739 2713317
0.21% APLS APELLIS PHARMACEUTICALS INC -- $98,041.76 5,072 BYTQ6X1
0.20% TWST TWIST BIOSCIENCE CORP -- $95,966.20 2,410 BGKG6G7
0.19% AMRX AMNEAL PHARMACEUTICALS INC -- $90,298.04 12,524 BFNF1D6
0.19% RXRX RECURSION PHARMACEUTICALS-A -- $87,956.13 15,963 BM9FJ13
0.18% IBRX IMMUNITYBIO INC -- $85,263.67 29,503 BNSP0B8
0.18% FOLD AMICUS THERAPEUTICS INC -- $83,422.08 12,414 B19FQ48
0.18% VCEL VERICEL CORP -- $83,243.37 2,019 BSBMN89
0.18% LGND LIGAND PHARMACEUTICALS -- $82,927.02 778 2501578
0.17% ZLAB ZAI LAB LTD-ADR -- $79,651.04 2,527 BD9GVY0
0.17% MIRM MIRUM PHARMACEUTICALS INC -- $78,388.20 1,980 BJDX8Y8
0.16% DNLI DENALI THERAPEUTICS INC -- $77,855.09 5,867 BD2B4V0
0.16% TARS TARSUS PHARMACEUTICALS INC -- $75,564.72 1,551 BMH5RL1
0.16% NVCR NOVOCURE LTD -- $73,498.55 4,441 BYSS4X4
0.15% -- NEWAMSTERDAM PHARMA CO NV -- $72,855.54 4,437 BP8JSP4
0.15% SUPN SUPERNUS PHARMACEUTICALS INC -- $71,258.00 2,255 B72ZBG4
0.15% JANX JANUX THERAPEUTICS INC -- $69,132.60 2,388 BMFX8Y7
0.14% HRMY HARMONY BIOSCIENCES HOLDINGS -- $68,421.01 2,317 BKSGZN7
0.14% KYMR KYMERA THERAPEUTICS INC -- $66,728.32 2,624 BMPRZV5
0.13% AGIO AGIOS PHARMACEUTICALS INC -- $63,708.80 2,315 BCBVTX1
0.13% ARWR ARROWHEAD PHARMACEUTICALS IN -- $62,872.30 5,095 BYQBFJ8
0.13% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $62,034.36 4,794 BKX9VD3
0.13% CGON CG ONCOLOGY INC -- $61,704.56 3,076 BRBCSP4
0.13% APGE APOGEE THERAPEUTICS INC -- $60,536.32 1,819 BM9HHL5
0.13% IDYA IDEAYA BIOSCIENCES INC -- $60,518.07 3,537 BK0VHF6
0.13% ANIP ANI PHARMACEUTICALS INC -- $60,404.88 879 BCDWBX6
0.13% BCRX BIOCRYST PHARMACEUTICALS INC -- $59,438.72 8,443 2100362
0.12% BEAM BEAM THERAPEUTICS INC -- $57,477.00 3,381 BK6L288
0.12% DVAX DYNAVAX TECHNOLOGIES CORP -- $57,348.72 5,013 BRJZSK0
0.12% SPRY ARS PHARMACEUTICALS INC -- $56,823.69 3,927 BMCR7V2
0.12% MNKD MANNKIND CORP -- $56,796.21 12,267 BF081J4
0.12% IRON DISC MEDICINE INC -- $56,257.19 1,397 BMGJZJ8
0.12% VERA VERA THERAPEUTICS INC -- $55,384.00 2,576 BL55460
0.11% TVTX TRAVERE THERAPEUTICS INC -- $53,180.38 3,586 BLFGJD5
0.10% OCUL OCULAR THERAPEUTIX INC -- $48,084.64 6,352 BNZB1X8
0.10% AMPH AMPHASTAR PHARMACEUTICALS IN -- $47,448.06 1,943 BNFWZS4
0.10% INDV INDIVIOR PLC -- $47,351.04 5,016 BP0BQQ5
0.10% EWTX EDGEWISE THERAPEUTICS INC -- $47,174.58 3,826 BKY5JZ8
0.10% PCRX PACIRA BIOSCIENCES INC -- $46,693.90 1,870 B3X26D8
0.10% ADPT ADAPTIVE BIOTECHNOLOGIES -- $46,630.66 5,963 BJ5FZ74
0.10% GPCR STRUCTURE THERAPEUTICS INC -- $45,612.65 2,407 BQS9486
0.10% INVA INNOVIVA INC -- $45,525.36 2,532 BDDXF67
0.10% IOVA IOVANCE BIOTHERAPEUTICS INC -- $45,175.68 13,248 BF0DMK7
0.09% CNTA CENTESSA PHARMACEUTICALS-ADR -- $44,046.66 3,689 BLB0YQ9
0.09% ARDX ARDELYX INC -- $44,013.67 9,631 BN89V40
0.09% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $43,098.92 1,601 BLCD809
0.09% AUPH AURINIA PHARMACEUTICALS INC -- $42,893.77 5,549 BFWLC09
0.09% NVAX NOVAVAX INC -- $41,658.59 6,499 BJDQXG4
0.08% SNDX SYNDAX PHARMACEUTICALS INC -- $38,766.76 3,449 BN7Q7R7
0.08% WVE WAVE LIFE SCIENCES LTD -- $36,978.00 6,163 BYZG9R0
0.08% TXG 10X GENOMICS INC-CLASS A -- $36,194.85 4,374 BKS3RS7
0.07% HROW HARROW INC -- $35,111.60 1,439 BHNDW86
0.07% KNSA KINIKSA PHARMACEUTICALS INTE -- $35,110.93 1,697 BRXB0C0
0.07% ETNB 89BIO INC -- $34,922.08 5,899 BK1K484
0.07% GRFS GRIFOLS SA-ADR -- $34,503.00 4,929 B8K7T65
0.07% DYN DYNE THERAPEUTICS INC -- $34,145.37 4,571 BN15WD1
0.07% COLL COLLEGIUM PHARMACEUTICAL INC -- $34,000.56 1,272 BX7RSN3
0.07% GERN GERON CORP -- $33,968.88 25,734 2370381
0.07% ELVN ENLIVEN THERAPEUTICS INC -- $33,933.06 1,974 BMFD115
0.07% GRAL GRAIL INC -- $33,746.30 1,358 BSLSSX7
0.07% GMAB GENMAB A/S -SP ADR -- $32,728.08 1,694 BBC9WC7
0.07% SYRE SPYRE THERAPEUTICS INC -- $31,703.70 2,435 BQBBDY8
0.07% NTLA INTELLIA THERAPEUTICS INC -- $31,372.50 4,183 BYZM6C2
0.07% VIR VIR BIOTECHNOLOGY INC -- $30,863.37 5,541 BK4PZ38
0.06% ZYME ZYMEWORKS INC -- $30,613.00 2,783 BPCQZY9
0.06% AVXL ANAVEX LIFE SCIENCES CORP -- $30,314.34 3,437 BYTYP72
0.06% NRIX NURIX THERAPEUTICS INC -- $30,200.10 3,066 BMVLGP2
0.06% AVDL AVADEL PHARMACEUTICALS -- $30,100.62 3,894 BDGMC59
0.06% CVAC CUREVAC NV -- $29,639.28 9,064 BN4RD42
0.06% DAWN DAY ONE BIOPHARMACEUTICALS I -- $29,565.90 4,095 BLB0YH0
0.06% ABCL ABCELLERA BIOLOGICS INC -- $29,377.60 12,040 BL53SR3
0.06% MLYS MINERALYS THERAPEUTICS INC -- $28,034.88 2,014 BP9N0G0
0.06% EOLS EVOLUS INC -- $26,280.93 2,559 BDRJH21
0.05% LENZ LENZ THERAPEUTICS INC -- $25,819.64 1,111 BQV0J03
0.05% RCKT ROCKET PHARMACEUTICALS INC -- $25,460.28 4,308 BDFKQ07
0.05% XNCR XENCOR INC -- $25,452.18 2,847 BGCYWN8
0.05% ABUS ARBUTUS BIOPHARMA CORP -- $25,111.68 7,656 BZ0QMB7
0.05% XERS XERIS BIOPHARMA HOLDINGS INC -- $25,059.84 6,024 BLR7H87
0.05% AVBP ARRIVENT BIOPHARMA INC -- $25,040.37 1,362 BMGTLY5
0.05% PRAX PRAXIS PRECISION MEDICINES I -- $24,246.25 815 BQ721R4
0.05% KALV KALVISTA PHARMACEUTICALS INC -- $23,864.15 1,997 BD06CS0
0.05% REPL REPLIMUNE GROUP INC -- $23,371.12 3,112 BDDVW37
0.05% CSTL CASTLE BIOSCIENCES INC -- $22,913.28 1,152 BKLCWZ3
0.05% ANAB ANAPTYSBIO INC -- $22,128.54 1,239 BDRW1L7
0.05% PRTA PROTHENA CORP PLC -- $21,619.50 2,175 B91XRN2
0.05% TRVI TREVI THERAPEUTICS INC -- $21,485.45 3,611 BJH9ZN0
0.04% COGT COGENT BIOSCIENCES INC -- $21,068.00 4,600 BLR6XK8
0.04% KROS KEROS THERAPEUTICS INC -- $20,880.86 1,639 BM7V485
0.04% ARVN ARVINAS INC -- $20,564.60 2,779 BDZ30Q0
0.04% SVRA SAVARA INC -- $20,108.60 6,934 BYXGN81
0.04% QURE UNIQURE NV -- $20,036.45 2,185 BJFSR88
0.04% FTRE FORTREA HOLDINGS INC -- $19,424.64 3,624 BRXYZ57
0.04% KURA KURA ONCOLOGY INC -- $19,088.55 3,263 BYZD465
0.04% HCM HUTCHMED CHINA-ADR -- $18,657.17 1,253 BYXV9H7
0.04% SAGE SAGE THERAPEUTICS INC -- $18,381.60 2,484 BP4GNK9
0.04% CGEM CULLINAN THERAPEUTICS INC -- $18,297.36 2,364 BM90J52
0.04% URGN UROGEN PHARMA LTD -- $18,073.00 1,705 BZ7PJQ1
0.04% SIGA SIGA TECHNOLOGIES INC -- $17,742.75 2,885 2107437
0.04% RLAY RELAY THERAPEUTICS INC -- $17,604.50 6,850 BN2R582
0.04% CRMD CORMEDIX INC -- $17,482.76 2,452 BJ0LT31
0.04% TBPH THERAVANCE BIOPHARMA INC -- $17,346.51 1,987 BMNDK09
0.04% MGTX MEIRAGTX HOLDINGS PLC -- $17,305.84 3,158 BFYQFJ2
0.04% TYRA TYRA BIOSCIENCES INC -- $17,239.35 2,045 BMVNDH9
0.04% PGEN PRECIGEN INC -- $16,566.20 11,833 BKM5C84
0.03% MNMD MIND MEDICINE MINDMED INC -- $16,444.65 2,963 BPQYY97
0.03% OMER OMEROS CORP -- $16,363.59 2,341 B4NB858
0.03% SANA SANA BIOTECHNOLOGY INC -- $16,328.01 9,021 BMFJJ97
0.03% STOK STOKE THERAPEUTICS INC -- $16,178.40 2,140 BJQ05Z6
0.03% EYPT EYEPOINT PHARMACEUTICALS INC -- $15,748.18 2,758 BMGS7L1
0.03% ZVRA ZEVRA THERAPEUTICS INC -- $15,055.86 2,157 BLFBZ32
0.03% VERV VERVE THERAPEUTICS INC -- $14,782.56 3,588 BNKGXX2
0.03% MESO MESOBLAST LTD- SPON ADR -- $14,756.76 1,374 BQS7491
0.03% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $14,722.02 822 BL95N25
0.03% ORIC ORIC PHARMACEUTICALS INC -- $14,665.70 2,870 BKVDFF7
0.03% PACB PACIFIC BIOSCIENCES OF CALIF -- $14,607.12 11,066 B4N8MH9
0.03% TRML TOURMALINE BIO INC -- $14,597.24 1,036 BQ80NC6
0.03% RAPP RAPPORT THERAPEUTICS INC -- $14,543.52 1,478 BR3T9B6
0.03% ALT ALTIMMUNE INC -- $14,408.56 3,112 BFY7DC4
0.03% ABSI ABSCI CORP -- $14,340.69 4,641 BN94K69
0.03% GLPG GALAPAGOS NV-SPON ADR -- $14,302.20 591 B292NQ7
0.03% ERAS ERASCA INC -- $14,165.76 11,424 BNLYBF3
0.03% AMLX AMYLYX PHARMACEUTICALS INC -- $13,501.80 3,462 BPCK358
0.03% RNAC CARTESIAN THERAPEUTICS INC -- $13,351.00 1,027 BQB9HM8
0.03% PHAT PHATHOM PHARMACEUTICALS INC -- $12,792.69 2,763 BJLKVS6
0.03% RGNX REGENXBIO INC -- $12,672.66 2,002 BZ0G875
0.03% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $12,577.53 1,779 BKDQKM6
0.03% ORKA ORUKA THERAPEUTICS INC -- $12,315.82 1,513 BKVF0J2
0.03% RIGL RIGEL PHARMACEUTICALS INC -- $12,253.52 712 BQD3J33
0.03% TKNO ALPHA TEKNOVA INC -- $12,213.18 2,154 BP7L561
0.03% OLMA OLEMA PHARMACEUTICALS INC -- $12,180.00 3,000 BMZ4LN0
0.03% ALLO ALLOGENE THERAPEUTICS INC -- $12,114.96 8,472 BFZNYB7
0.03% TRDA ENTRADA THERAPEUTICS INC -- $12,030.48 1,519 BP81RK8
0.02% PSNL PERSONALIS INC -- $11,553.84 3,566 BJQ0608
0.02% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $11,136.92 1,094 BKC9SX3
0.02% MXCT MAXCYTE INC -- $11,081.20 4,262 BKMQF66
0.02% AURA AURA BIOSCIENCES INC -- $10,998.10 2,018 BP81R42
0.02% GLUE MONTE ROSA THERAPEUTICS INC -- $10,945.62 2,482 BP7KZP7
0.02% AUTL AUTOLUS THERAPEUTICS PLC -- $10,851.32 8,098 BFMLGR4
0.02% TECX TECTONIC THERAPEUTIC INC -- $10,650.52 596 BPBPCG8
0.02% TSHA TAYSHA GENE THERAPIES INC -- $10,602.24 8,283 BNC1BX1
0.02% TSVT 2SEVENTY BIO INC -- $10,336.64 2,084 BMTXV88
0.02% ALMS ALUMIS INC -- $10,284.12 1,908 BPLQG36
0.02% VNDA VANDA PHARMACEUTICALS INC -- $10,272.16 2,356 B12W3P6
0.02% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $10,143.87 5,731 BMCWKZ2
0.02% AVIR ATEA PHARMACEUTICALS INC -- $10,034.22 3,413 BLN9Z50
0.02% ATXS ASTRIA THERAPEUTICS INC -- $9,621.60 2,280 BMYRFN8
0.02% OABI OMNIAB INC -- $9,437.70 4,890 BN13S71
0.02% AQST AQUESTIVE THERAPEUTICS INC -- $9,283.68 3,684 BYVQJ96
0.02% THRD THIRD HARMONIC BIO INC -- $9,268.89 1,821 BNNPQY8
0.02% YMAB Y-MABS THERAPEUTICS INC -- $8,923.30 1,810 BG31GH0
0.02% SLRN ACELYRIN INC -- $8,870.42 4,069 BQPF874
0.02% SLDB SOLID BIOSCIENCES INC -- $8,357.64 3,084 BQHN6C7
0.02% CRGX CARGO THERAPEUTICS INC -- $8,295.60 1,860 BQHN2F2
0.02% ITOS ITEOS THERAPEUTICS INC -- $8,162.28 1,476 BMWXFT4
0.02% FHTX FOGHORN THERAPEUTICS INC -- $8,066.73 2,247 BMF7DT9
0.02% ESPR ESPERION THERAPEUTICS INC -- $7,953.84 7,961 BBNBTD2
0.02% TERN TERNS PHARMACEUTICALS INC -- $7,927.92 3,432 BMDJ0C9
0.02% CRVS CORVUS PHARMACEUTICALS INC -- $7,865.88 2,596 BYP80F1
0.02% HUMA HUMACYTE INC -- $7,746.51 5,199 BMYTJP4
0.02% LXRX LEXICON PHARMACEUTICALS INC -- $7,741.18 14,606 BWFZX59
0.02% CDXS CODEXIS INC -- $7,698.10 3,347 B5LL2C2
0.02% -- AMARIN CORP PLC ADR USD 10 -- $7,661.23 809 --
0.02% CMPS COMPASS PATHWAYS PLC -- $7,577.18 2,509 BMC3HS7
0.02% DSGN DESIGN THERAPEUTICS INC -- $7,436.00 2,288 BMFK3H6
0.02% TVGN TEVOGEN BIO HOLDINGS INC -- $7,426.65 7,073 BPG5P75
0.01% PRME PRIME MEDICINE INC -- $7,049.00 5,300 BPBJFM7
0.01% VYGR VOYAGER THERAPEUTICS INC -- $7,040.33 2,207 BY7RB53
0.01% INBX INHIBRX BIOSCIENCES INC -- $6,949.80 585 BNSP8K3
0.01% ANNX ANNEXON INC -- $6,589.71 4,307 BMVV9R5
0.01% NGNE NEUROGENE INC -- $6,534.00 600 BS2F741
0.01% ACIU AC IMMUNE SA -- $6,073.92 3,996 BZC0D70
0.01% TNGX TANGO THERAPEUTICS INC -- $5,853.12 4,368 BP2P6L0
0.01% LYEL LYELL IMMUNOPHARMA INC -- $5,248.50 11,805 BN6MB18
0.01% SCPH SCPHARMACEUTICALS INC -- $5,216.76 2,022 BYX2Z16
0.01% FDMT 4D MOLECULAR THERAPEUTICS IN -- $5,201.38 1,871 BKLXFX5
0.01% SLN SILENCE THERAPEUTICS PLC-ADR -- $5,149.00 1,900 BL5B6Z1
0.01% NKTX NKARTA INC -- $4,846.70 2,851 BK80YJ8
0.01% LRMR LARIMAR THERAPEUTICS INC -- $4,820.86 2,578 BMXNGZ6
0.01% EDIT EDITAS MEDICINE INC -- $4,402.20 3,335 BZ8FPH3
0.01% NMRA NEUMORA THERAPEUTICS INC -- $4,372.45 6,528 BN4JN37
0.01% FATE FATE THERAPEUTICS INC -- $4,253.63 4,602 BCZS820
0.01% ENTA ENANTA PHARMACEUTICALS INC -- $4,249.66 862 B9L5200
0.01% IRWD IRONWOOD PHARMACEUTICALS INC -- $4,189.32 6,466 B3MZ6K5
0.01% ALEC ALECTOR INC -- $3,927.12 4,004 BJ4LDC4
0.01% KYTX KYVERNA THERAPEUTICS INC -- $3,889.12 1,744 BSMLR16
0.01% CLYM CLIMB BIO INC -- $3,557.96 2,716 BMW5LX6
0.01% CCCC C4 THERAPEUTICS INC -- $3,527.64 2,868 BKX9NQ0
0.01% PLRX PLIANT THERAPEUTICS INC -- $3,491.78 2,459 BMDWW66
0.01% MGNX MACROGENICS INC -- $3,220.72 2,536 BFDV8K0
0.01% LXEO LEXEO THERAPEUTICS INC -- $2,859.04 1,336 BQ6C357
0.01% INZY INOZYME PHARMA INC -- $2,515.78 2,596 BMVLGY1
0.01% TCRX TSCAN THERAPEUTICS INC -- $2,460.16 1,984 BNLYBJ7
0.01% BMEA BIOMEA FUSION INC -- $2,371.68 1,464 BNKF6N0
-- PYXS PYXIS ONCOLOGY INC -- $2,198.75 2,403 BLBR8D5
-- STRO SUTRO BIOPHARMA INC -- $1,988.87 3,332 BF12XC2
-- ARTV ARTIVA BIOTHERAPEUTICS INC -- $1,922.76 981 BMF1LJ7
-- ACRV ACRIVON THERAPEUTICS INC -- $1,887.00 1,258 BP2TPK4
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $1,761.30 9,785 BM9HFX3
-- APLT APPLIED THERAPEUTICS INC -- $1,734.67 4,701 BJL38Z1
-- MRSN MERSANA THERAPEUTICS INC -- $1,654.02 4,991 BF3NP05
-- IGMS IGM BIOSCIENCES INC -- $1,638.63 1,377 BKS3SM8
-- OKUR ONKURE THERAPEUTICS INC-A -- $1,553.44 511 BT7KGT6
-- PEPG PEPGEN INC -- $1,453.10 1,321 BMTX3D7
-- QTTB Q32 BIO INC -- $944.64 492 BS2FKQ4
33.67% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 15,927,647 -- 3,956 --
26.26% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 12,424,853 -- 3,086 --
20.60% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 9,743,404 -- 2,420 --
17.75% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 8,398,653 -- 2,086 --
17.62% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 8,334,234 -- 2,070 --
8.09% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 3,824,890 -- 950 --
-- -- UNITED STATES OF AMERICA BILL ZERO CPN 27/MAY/2025 USD 100 -- $7,462,847.48 7,500,000 --
-- -- TREASURY BILL -- $3,983,504.32 4,000,000 BSZBFQ4
-- -- TREASURY BILL -- $2,977,968.36 3,000,000 BSNQ2D7
-- -- UNITED STATES OF AMERICA BILL ZERO CPN 26/JUN/2025 USD 100 -- $743,679.56 750,000 --
-- -- NET OTHER ASSETS (LIABILITIES) -- $-3,396,794.34 -3,396,794 --

Index

as of 3/31/2025

  • Total Number of Companies264
  • Price/Earnings Ratio--
  • Price/Book Ratio4.157
  • Dividend Yield ( % )0.88
  • Avg. Index Market Capitalization$5.80 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.